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Electrocardiogram with prolonged QT interval in Gitelman characteristic set of metabolic abnormalities that include
disease. hypokalemia and alkalosis [1–6]. The constellation of
Background. Potassium and magnesium deficiency prolong findings in Bartter syndrome result from a variety ofthe QT interval on a standard electrocardiogram and pre-
renal tubular defects [1–6]. Gitelman disease (Mendeliandispose the patient to dangerous cardiac arrhythmias. No infor-
Inheritance in Man # 263800) is also known as the mildmation is available on QT interval in patients diagnosed with
Gitelman disease. variant of Bartter syndrome, as this disease sometimes
Methods. The QT interval was assessed on lead II in 27 pa- is diagnosed during routine investigation. In addition
tients with biochemically and genetically defined Gitelman dis- to hypokalemia and alkalosis, patients with Gitelmanease, who had discontinued medical treatment for at least four
disease display magnesium depletion and a relatively lowweeks. They included 15 female and 12 male subjects, aged
urinary calcium excretion. Inactivating mutations in the6.7 to 40 years old, median 20 years old. The corrected QT in-
terval was calculated from the measured QT interval and heart thiazide-sensitive sodium-chloride cotransporter gene
rate using the Bazett formula. cause the disease [1–6].
Results. The corrected QT interval was normal (between
Potassium and magnesium deficiency secondary to loss391 and 433 msec) in 16 and prolonged in the remaining 11 pa-
of gastric or intestinal secretions, to eating disorders ortients (between 444 and 504 msec). Patients with prolonged
and patients with normal QT interval did not significantly differ to use of drugs prolong the repolarization of ventricular
with respect to female to male ratio, plasma potassium, plasma cardiomyocytes and predispose to dangerous ventricular
total magnesium, and plasma ionized calcium. Plasma sodium arrhythmias [7–10]. A prolonged QT interval on stan-
and chloride values were slightly but significantly lower and bi-
dard electrocardiogram is a simple estimate of extendedcarbonate levels higher in patients with a prolonged than in
ventricular repolarization that is assumed to impart anthose with a normal QT interval.
Conclusions. The corrected QT interval is often pathologi- increased risk for development of a ventricular arrhyth-
cally prolonged in patients with Gitelman disease, suggest- mia culminating in syncope or sudden death [7–10]. To
ing that there is an increased risk for development of danger- the best of our knowledge, no information is available
ous arrhythmias. Further investigations are required in patients
on the occurrence of unexplained syncope and suddenwith a prolonged QT interval to assess the true hazard of
death in Gitelman disease, as indicated by the fact thatdangerous arrhythmias.
none of the recently published reviews dealing with the
diagnosis and management of Gitelman disease refer to
these risk factors or suggest that an electrocardiogramThe term normotensive renal hypokalemic alkalosis
or, more frequently, the eponym Bartter syndrome is cur- should be recorded [1–6]. This is the first systematic
rently used to describe an inherited renal disorder with a analysis on QT interval in patients with clinically, bio-
chemically and genetically defined Gitelman disease.
Key words: electrocardiogram, hypokalemia, hypomagnesemia, car-
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Italy (N  21) and Switzerland (N  5). They included V2 [14, 15]. The QT interval was measured manually
from the earliest onset of the QRS complex to the latestfive families, each with two patients, and 17 families with
one participant patient each. Apart from absent arterial point at which the T wave crosses the baseline (U waves
were not measured as part of the QT interval). The QThypertension, the diagnosis of Gitelman disease was
based on the following criteria [11]: (1) hypokalemia of interval and preceding RR intervals were measured for
five consecutive cycles and averaged. The QT intervalrenal origin, defined as plasma potassium 3.6 mmol/L
and fractional potassium excretion 15.0  102; (2) corrected for heart rate was calculated from the mea-
sured QT interval and from heart rate (RR interval)plasma bicarbonate27.0 mmol/L; (3) hypomagnesemia
of renal origin, defined as plasma magnesium 0.70 using the Bazett formula [15]. The normal value for the
corrected QT interval is 440 msec [15].mmol/L and fractional magnesium excretion 4.00 
102; (4) fractional chloride excretion0.500 102; (5) The two-tailed Kruskal-Wallis test (nonparametric
analysis of variance for independent samples) with theurinary calcium/creatinine ratio 0.100 mol/mol. Muta-
tions in the thiazide-sensitive sodium chloride cotrans- Bonferroni adjustment, followed by a posteriori multi-
variate analysis, and Bland-Altman residual analysis wereporter gene had been identified in 18 out of the 27 pa-
tients by single stranded conformation polymorphism, used for analysis. Test for bimodality was performed
using the Lilliefors test, a recognized modification of theusing polymerase chain reaction (PCR) primers designed
from intronic sequences surrounding all exons of the Kolmogorov-Smirnov normality test. Significance was
assumed when P  0.05.gene, as previously described [12, 13].
None of the 27 Gitelman patients had a history of
unexplained loss of consciousness with postural collapse,
RESULTS
non-febrile seizures, chest discomfort, palpitations and
Hypokalemia (plasma potassium ranging from 2.61 toexertional or nocturnal shortness of breath. In addition,
3.50 mmol/L), metabolic alkalosis (plasma bicarbonatea meticulous clinical examination failed to reveal any
from 27.3 to 39.5 mmol/L) and hypomagnesemia (plasmacardiovascular abnormality.
magnesium from 0.44 to 0.69 mmol/L) were noted in allAt the time of the study the patients had not taken
27 patients with Gitelman disease (Table 1). Patientsany medication for at least one month. They had been
with Gitelman disease and control subjects did not sig-instructed to collect urine during 24 hours for determina-
nificantly differ with respect to age, female-to-male ratio,tion of creatinine and to attend the outpatient clinic after
body weight, arterial pressure, glomerular filtration rateovernight fasting. Body weight, height and sitting arterial
and plasma sodium. Plasma chloride and ionized calciumpressure were measured, and a blood sample collected
were significantly lower and plasma total protein higherwith minimal stasis and without movements of the fore-
in the group of patients with Gitelman disease than inarm. The hydrogen ion concentration, carbon dioxide
the control group (Table 1).pressure, sodium, potassium, chloride, ionized calcium,
Depression of the ST segment 0.5 mm, flat or lowtotal magnesium and protein, and creatinine were as-
amplitude T waves, and U waves amplitudes 1 mmsessed in blood. The mentioned laboratory values also
were not observed in the 27 Gitelman patients. The QTwere assessed in a control group of 27 healthy subjects
interval measured on lead II varied from 542 to 647,matched for age and sex. Finally, all patients underwent
median 580 msec, and that measured on lead V2 varieda standard 12-lead resting electrocardiogram.
from 541 to 650, median 578 msec. The comparison ofBlood hydrogen ion concentration, blood carbon di-
the QT interval measured on lead II and that measuredoxide pressure, plasma sodium, potassium, chloride and
on lead V2 by means of the Bland-Altman residual analy-ionized calcium were measured using selective electrodes
sis given in Figure 1 indicates that the difference betweenimmediately after collection. Plasma bicarbonate was cal-
leads is not clinically important and that the two methodsculated from blood hydrogen concentration and blood car-
of measurement can be used interchangeably. As a con-bon dioxide pressure according to the Henderson-Has-
sequence only the numbers measured on lead II, theselbalch equation. Plasma total protein (biuret method)
most commonly used measurement in clinical routine,and plasma and urinary creatinine (kinetic alkaline pic-
will be used in this article.rate method) were determined by colorimetry. Plasma
The lead II QT interval corrected for heart rate rangedtotal magnesium was assessed by atomic absorption spec-
between 391 and 504 msec in the 27 Gitelman patients.trophotometry.
It was normal (between 391 and 433 msec) in 16 andThe glomerular filtration rate was calculated from
prolonged in the remaining 11 patients. (The QT intervalcreatinine clearance. The electrocardiogram was inde-
was assessed again three to ten months later in seven ofpendently analyzed by two experienced cardiologists
the patients with a prolonged QT interval. Again, the cor-who were unaware of the patient’s diagnosis. The QT
rected QT interval on lead II was 440 msec.) The cor-intervals were assessed at a paper speed of 50 mm/sec
and an amplification of 0.1 mV/mm both on leads II and rected QT interval ranged between 444 and 491 msec in
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Table 1. Clinical and laboratory parameters in 27 patients with Gitelman disease and in 27 control subjects
Patients with Gitelman disease
Corrected QT-interval Corrected QT-interval
All patients normal prolonged Control subjects
N 27 16 11 27
Age years 20 (14–25) 23 (16–26) 17 (13–19)c 20 (14–26)
Gender, female:male 15:12 9:7 6:5 15:12
Body weight kg 52.0 (44.1–56.6) 55.9 (51.6–58.8) 44.5 (42.2–50.9)c 56.7 (47.5–61.1)
Height m 1.59 (1.45–1.71) 1.62 (1.53–1.74) 1.45 (1.37–1.52)c 1.66 (1.59–1.74)
Arterial pressure mm Hg 113 (105–117)/76 (53–78) 117 (105–127)/77 (69–80) 114 (111–120)/74 (62–75) 120 (113–130)/76 (68–83)
Heart rate per min 64.4 [61.9–70.1] 64.2 [61.3–69.2] 64.4 [62.4–70.1] 63.0 [59.5–71.4]
Plasma potassiuma
mmol/L 3.02 (2.90–3.39) 2.96 (2.82–3.35) 3.01 (2.89–3.38) 4.52 (4.40–4.74)
Plasma bicarbonatea
mmol/L 33.4 (30.3–34.1) 31.6 (28.9–33.5) 34.2 (33.0–38.0)c 25.2 (24.3–26.7)
Total plasma magnesiuma
mmol/L 0.59 (0.55–0.64) 0.59 (0.54–0.61) 0.61 (0.57–0.67) 0.79 (0.74–0.83)
Glomerular filtration rate
mL/min1.73 m2 106 (101–115) 105 (99–116) 107 (105–114) 110 (95–115)
Plasma sodium mmol/L 140.0 (138.2–141.5) 140.6 (139.8–142.0) 138.3 (137.0–140.1)c 40.0 (138.1–142.0)
Plasma chloride mmol/L 101 (98–103)a 102 (101–104) 98 (96–102)c 107 (106–108)
Plasma ionized calcium
mmol/L 1.30 (1.23–1.35)b 1.30 (1.22–1.33) 1.31 (1.26–1.36) 1.36 (1.32–1.39)
Plasma total protein g/L 77.0 (75.2–79.3)b 76.9 (75.0–78.9) 77.0 (75.6–79.8) 73.3 (70.1–77.2)
Measured QT interval
(lead II)a msec 585 (565–604) 568 (552–575) 616 (600–637) —
Corrected QT interval
(lead II)a msec 429 (421–466) 423 (409–482) 471 (463–482) —
Results are given either as absolute values or as as median and interquartile range (which extends from the value at centile 25 to the value at centile 75 and
includes half of the data points).
a Patients and control subjects, respectively patients with a normal and patients with a prolonged QT interval were not compared; a significant difference was
predictable as the value was by definition abnormal in one of the groups
b P  0.01 vs. control subjects
c P  0.05 vs. patients with normal corrected QT interval
Fig. 1. Comparison of the QT intervals measured on lead II and the
QT measured on anteroseptal lead V2 by means of the Bland Altman
diagram of residual analysis in 27 patients with Gitelman disease. The
measured QT interval on the average was lower by 1 msec on lead II than Fig. 2. Frequency distribution of the QT interval corrected for hearton lead V2. Furthermore, the clinically irrelevant limits of agreement, rate on lead II in 27 patients with Gitelman disease. The diagramnamely the differences within mean  2 SD of 9 msec indicate that indicates the possible existence of a bimodal distribution (P  0.05).lead II and lead V2 can be used interchangeably. Please note that the The vertical dotted line separates normal from increased QT intervalsdiagram presents the measured QT interval and not the corrected QT corrected for heart rate. Symbols are: ( ) females; () males.interval calculated from the measured QT interval and heart rate using
the Bazett formula.
the five families with two patients in each disclosed the
following: in three families the QT interval corrected for10 patients and was500 msec (504 msec) in one patient.
heart rate was normal in both patients, in one family theThe frequency distribution of the QT interval corrected
interval was prolonged in both patients, and in one familyfor heart rate indicates the possible existence of a bi-
modal distribution (P  0.05; Fig. 2). The analysis of it was normal in the first and prolonged in the second
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patient. Patients with a normal and patients with a pro- tricular arrhythmias [7–10]. A QT prolongation can be
inherited or acquired as an adverse response to medica-longed QT interval did not significantly differ with re-
spect to the female-to-male ratio, arterial pressure, glo- tion or metabolic abnormalities [7–19]. The inherited
causes of prolonged QT interval result from an intrinsicmerular filtration rate, plasma potassium, plasma total
magnesium, and plasma ionized calcium. Total plasma abnormality in the mechanisms responsible for cardiac
repolarization. The defect underlying Gitelman diseaseprotein was significantly higher in patients.
Patients with a prolonged corrected QT interval were is an abnormality in the gene coding for the thiazide-
sensitive sodium chloride cotransporter in the distal tu-slightly younger, smaller and lighter than patients with-
out it. In addition, plasma sodium and chloride values bule [1–6, 13, 17]. This gene is not expressed in heart
tissue [12]. Therefore, it is assumed that the QT prolon-were slightly but significantly lower and bicarbonate
higher in patients with a prolonged than in those with a gation noted in our patients with Gitelman disease does
not directly result from an altered intracardial expressionnormal QT interval. In the 27 patients with Gitelman
disease no significant correlation was noted between cir- of the thiazide-sensitive sodium chloride cotransporter.
The analysis of the families each with two patients in-culating potassium, magnesium, calcium or bicarbonate
values, taken as independent values, and the corrected cluded in our study further supports this hypothesis.
The results of the present study are not surprising. ItQT interval, taken as dependent value. To estimate the
independent contribution of the measured variables to is well known that electrolyte disturbances such as those
noted in Gitelman disease, namely moderate to severethe variance of the corrected QT interval, a multiple
regression analysis was performed with gender, age, and hypokalemia and hypomagnesemia, and a mild tendency
toward hypocalcemia, may result in QT prolongationcirculating sodium, chloride and bicarbonate as indepen-
dent variables. Among these variables, sodium and chlo- [7–10]. We failed to observe any significant correlation
between extracellular levels of the mentioned electro-ride contributed significantly (P  0.05) to the variance
of QT, whereas gender, age and chloride did not. lytes and the corrected QT interval. Apart from the rather
small size of patients with this rare disease included in
the study, a possible explanation for this result is that
DISCUSSION
circulating electrolytes may not be representative of the
The results of the present study demonstrate a prolon- corresponding myocardial levels. A complementary ex-
gation of the QT interval, which is likely stable over planation is that it is the altered potassium gradient
time, in more than 40% of the patients with Gitelman across the cardiomyocytic membrane that induces changes
disease. Similar findings have been previously reported on the electrocardiogram. In our patients, however, the
in a very heterogeneous group of patients with normo- intramyocardial potassium concentration, and thus the
tensive renal hypokalemic alkalosis [16]. corresponding gradient across cell membrane, is un-
Gitelman disease is a rare autosomal recessive disor- known. A further explanation is that potassium-, magne-
der that is often not diagnosed until late childhood or sium- and calcium-deficiency act in concert to prolong
even adulthood. The disease is considered a benign vari- the repolarization of ventricular cardiomyocytes [7–9].
ant of Bartter syndrome that is sometimes asymptomatic. In our patients circulating sodium, chloride and bicar-
However, the disease is usually symptomatic and associ- bonate weakly predicted the duration of the corrected
ated with clinical manifestations. Cramps are observed QT interval. These correlations, which also have been
in almost all patients. Affected patients may also present noted in anorexia nervosa [18], support the traditional
with tetany, particularly in association with vomiting and assumption that in Bartter syndrome and its variants,
diarrhea. Fatigue also may be observed and a lower than chloride depletion plays a pivotal role in the develop-
average blood pressure may be seen, consistent with the ment of hypokalemia and alkalosis [19].
tendency to salt wasting. Polyuria and nocturia are found A prolongation of the QT interval imparts a relevant
in a minority of these patients. As in other diseases with risk for development of a ventricular arrhythmia if there
recessive mode of inheritance, in Gitelman disease there is history of syncope or if the corrected QT interval is
is no direct correlation between the clinical phenotype longer than 500 msec [10, 20]. Consequently, no more
and the underlying genotypic abnormality [1–6, 17]. than one of our 27 patients is considered to have a high
In some heart diseases estimates of QT interval may probability of developing a dangerous arrhythmia. Fur-
vary in different leads [14, 15]. In our Gitelman patients ther studies will be needed to show whether the mild
the QT interval that had been measured manually by two QT prolongation noted in a large subset of our patients
experienced cardiologists was very similar in lead II and with Gitelman disease is relevant to their prognosis.
in lead V2. We believe that the results of the study have at least
A prolonged QT interval is present when the corrected four possible implications: (1) It may be prudent to evalu-
QT interval is more than 440 msec [14, 15]. It represents ate all Gitelman patients for the possible occurrence of
a syncope and to repeatedly record an electrocardio-a phenotypic description predisposing to dangerous ven-
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